These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15681910)

  • 1. The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases.
    Kong SC; Hurlstone DP; Pocock CY; Walkington LA; Farquharson NR; Bramble MG; McAlindon ME; Sanders DS
    J Clin Gastroenterol; 2005 Feb; 39(2):138-41. PubMed ID: 15681910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
    Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
    Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.
    Sirois FM
    Complement Ther Med; 2014 Aug; 22(4):701-9. PubMed ID: 25146075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
    Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of complementary therapies by patients with IBD may indicate psychosocial distress.
    Langmead L; Chitnis M; Rampton DS
    Inflamm Bowel Dis; 2002 May; 8(3):174-9. PubMed ID: 11979137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey.
    Hilsden RJ; Meddings JB; Verhoef MJ
    Can J Gastroenterol; 1999 May; 13(4):327-32. PubMed ID: 10360993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
    Quattropani C; Ausfeld B; Straumann A; Heer P; Seibold F
    Scand J Gastroenterol; 2003 Mar; 38(3):277-82. PubMed ID: 12737442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary medicine use in children and young adults with inflammatory bowel disease.
    Heuschkel R; Afzal N; Wuerth A; Zurakowski D; Leichtner A; Kemper K; Tolia V; Bousvaros A
    Am J Gastroenterol; 2002 Feb; 97(2):382-8. PubMed ID: 11866277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
    Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
    Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
    Opheim R; Hoivik ML; Solberg IC; Moum B;
    J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.
    Oxelmark L; Lindberg A; Löfberg R; Sternby B; Eriksson A; Almer S; Befrits R; Fossum B; Karlén P; Broström O; Tysk C;
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1320-8. PubMed ID: 27472271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey.
    Serpico MR; Boyle BM; Kemper KJ; Kim SC
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):651-657. PubMed ID: 26960176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine (CAM) practices and dietary patterns in children with inflammatory bowel disease in Singapore and Malaysia.
    Ong F; Seah Lee W; Lin C; Ng RT; Yee Wong S; Lim SL; Quak SH; Aw M
    Pediatr Neonatol; 2018 Oct; 59(5):494-500. PubMed ID: 29352665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
    Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
    J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and Alternative Medicine Use Is Prevalent Among Patients with Gastrointestinal Diseases.
    Hung A; Kang N; Bollom A; Wolf JL; Lembo A
    Dig Dis Sci; 2015 Jul; 60(7):1883-8. PubMed ID: 25556585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
    Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
    J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
    Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
    Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile.
    Fernández A; Simian D; Quera R; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Fluxá D
    Complement Ther Med; 2018 Oct; 40():77-82. PubMed ID: 30219473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.